Is plasminogen activator inhibitor-1 a physiological bottleneck bridging major depressive disorder and cardiovascular disease?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is plasminogen activator inhibitor-1 a physiological bottleneck bridging major depressive disorder and cardiovascular disease?
Authors
Keywords
-
Journal
Acta Physiologica
Volume 219, Issue 4, Pages 715-727
Publisher
Wiley
Online
2016-06-01
DOI
10.1111/apha.12726
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment
- (2016) Frank M. Schmidt et al. Current Neuropharmacology
- A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
- (2016) D R Goldsmith et al. MOLECULAR PSYCHIATRY
- Preexisting mild sleep disturbance as a vulnerability factor for inflammation-induced depressed mood: a human experimental study
- (2016) H J Cho et al. Translational Psychiatry
- Epidemiology of venous thromboembolism (VTE) associated with pregnancy
- (2015) Leonid A. Parunov et al. BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
- Relationship between Circulating Tumor Cells, Blood Coagulation, and Urokinase-Plasminogen-Activator System in Early Breast Cancer Patients
- (2015) Michal Mego et al. Breast Journal
- The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction
- (2015) Tajinder Kumar Parpugga et al. DISEASE MARKERS
- Antidepressant-like effect of n-3 PUFAs in CUMS rats: role of tPA/PAI-1 system
- (2015) Mimi Tang et al. PHYSIOLOGY & BEHAVIOR
- High Incidence of ACE/PAI-1 in Association to a Spectrum of Other Polymorphic Cardiovascular Genes Involving PBMCs Proinflammatory Cytokines in Hypertensive Hypercholesterolemic Patients: Reversibility with a Combination of ACE Inhibitor and Statin
- (2015) Jeanne d’Arc AlBacha et al. PLoS One
- The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis
- (2015) Leonardo Lorente et al. PLoS One
- Tissue plasminogen activator inhibits NMDA-receptor-mediated increases in calcium levels in cultured hippocampal neurons
- (2015) Samuel D. Robinson et al. Frontiers in Cellular Neuroscience
- Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
- (2015) Arnaud Chevilley et al. Frontiers in Cellular Neuroscience
- Predictive value of ankle-brachial index and PAI-1 in symptomatic intracranial atherosclerotic disease recurrence
- (2014) A. Massot et al. ATHEROSCLEROSIS
- Ideal Cardiovascular Health
- (2014) Vanessa Xanthakis et al. CIRCULATION
- A review of the relationship between proinflammatory cytokines and major depressive disorder
- (2014) Juan Joseph Young et al. JOURNAL OF AFFECTIVE DISORDERS
- Blood coagulation and fibrinolysis in patients with Cushing’s syndrome: Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels
- (2014) C. Erem et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- 17β-Estradiol Differentially Regulates Stress Circuitry Activity in Healthy and Depressed Women
- (2014) Emily G Jacobs et al. NEUROPSYCHOPHARMACOLOGY
- Roux-en-Y Gastric Bypass Decreases Pro-inflammatory and Thrombotic Biomarkers in Individuals with Extreme Obesity
- (2014) Bárbara Dal Molin Netto et al. OBESITY SURGERY
- Exogenous t-PA Administration Increases Hippocampal Mature BDNF Levels. Plasmin- or NMDA-Dependent Mechanism?
- (2014) Marion Rodier et al. PLoS One
- The association between sleep characteristics and prothrombotic markers in a population-based sample: Chicago Area Sleep Study
- (2014) Zehra Tosur et al. SLEEP MEDICINE
- Functional Stability of Plasminogen Activator Inhibitor-1
- (2014) Songul Yasar Yildiz et al. TheScientificWorldJOURNAL
- Residual vein thrombosis and onset of post-thrombotic syndrome: Influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene
- (2014) Egle Incalcaterra et al. THROMBOSIS RESEARCH
- The role of coagulation/fibrinolysis during Streptococcus pyogenes infection
- (2014) Torsten G. Loof et al. Frontiers in Cellular and Infection Microbiology
- Depression With Atypical Features and Increase in Obesity, Body Mass Index, Waist Circumference, and Fat Mass
- (2014) Aurélie M. Lasserre et al. JAMA Psychiatry
- Prognostic Value of Depression, Anxiety, and Anger in Hospitalized Cardiovascular Disease Patients for Predicting Adverse Cardiac Outcomes
- (2013) Shunichi Nakamura et al. AMERICAN JOURNAL OF CARDIOLOGY
- The Epidemiology of Depression Across Cultures
- (2013) Ronald C. Kessler et al. Annual Review of Public Health
- Depression and cardiovascular disease: a clinical review
- (2013) D. L. Hare et al. EUROPEAN HEART JOURNAL
- Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension
- (2013) Cristiana Catena et al. JOURNAL OF HYPERTENSION
- BDNF: an indicator of insomnia?
- (2013) M Giese et al. MOLECULAR PSYCHIATRY
- Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)
- (2013) M L Molendijk et al. MOLECULAR PSYCHIATRY
- Association of Plasminogen Activator Inhibitor-Type 1 (-675 4G/5G) Polymorphism with Pre-Eclampsia: Systematic Review
- (2013) Jessie A. Morgan et al. PLoS One
- Depression and Cardiovascular Disease
- (2013) Larkin Elderon et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Self-reported sleep disturbance is associated with elevated levels of PAI-1 in individuals with a recorded history of depressive symptoms
- (2013) Antti-Pekka Elomaa et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Risk of first venous thromboembolism in pregnant women in hospital: population based cohort study from England
- (2013) A. Abdul Sultan et al. BMJ-British Medical Journal
- Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010
- (2013) Alize J. Ferrari et al. PLOS MEDICINE
- Plasminogen activator inhitor-1 associates with cardiovascular risk factors in healthy young adults in the Cardiovascular Risk in Young Finns Study
- (2012) Juho R.H. Raiko et al. ATHEROSCLEROSIS
- Do negative emotional factors have independent associations with excess adiposity?
- (2012) Misty A.W. Hawkins et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- Heartache and heartbreak—the link between depression and cardiovascular disease
- (2012) Charles B. Nemeroff et al. Nature Reviews Cardiology
- BDNF Val66Met Impairs Fluoxetine-Induced Enhancement of Adult Hippocampus Plasticity
- (2012) Kevin G Bath et al. NEUROPSYCHOPHARMACOLOGY
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
- (2012) Kenji Hashimoto PROGRESS IN NEUROBIOLOGY
- Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: The prospective Sydney Memory and Aging Study
- (2012) B.T. Baune et al. PSYCHONEUROENDOCRINOLOGY
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets
- (2012) R. S. Duman et al. SCIENCE
- Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection
- (2011) Md. Shenuarin Bhuiyan et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Coagulation and prothrombotic state parameters: a clinical analysis during early pregnancy
- (2011) H. Chen et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies
- (2011) Chiara Baglioni et al. JOURNAL OF AFFECTIVE DISORDERS
- PAI-1 in tissue fibrosis
- (2011) Asish K. Ghosh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Intravenous Thrombolytic Therapy for Acute Ischemic Stroke
- (2011) Lawrence R. Wechsler NEW ENGLAND JOURNAL OF MEDICINE
- The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
- (2011) Bun-Hee Lee et al. Psychiatry Investigation
- Forty Years Later and the Role of Plasminogen Activator Inhibitor Type 2/SERPINB2 Is Still an Enigma
- (2011) Jodi Lee et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Pre-eclampsia
- (2010) Eric AP Steegers et al. LANCET
- The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases
- (2009) Hunjoo Ha et al. Nature Reviews Nephrology
- Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
- (2009) Reinhard Gabathuler NEUROBIOLOGY OF DISEASE
- Neurocircuitry of Mood Disorders
- (2009) Joseph L Price et al. NEUROPSYCHOPHARMACOLOGY
- A Reproductive Subtype of Depression
- (2009) Jennifer L. Payne et al. HARVARD REVIEW OF PSYCHIATRY
- General Cardiovascular Risk Profile for Use in Primary Care
- (2008) Ralph B. D’Agostino et al. CIRCULATION
- A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
- (2008) André Russowsky Brunoni et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Major Depressive Disorder
- (2008) R.H. Belmaker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment response
- (2008) Shih-Jen Tsai et al. Pharmacogenetics and Genomics
- Cardiovascular, Inflammatory, and Metabolic Consequences of Sleep Deprivation
- (2008) Janet M. Mullington et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Association between Anxiety and Factors of Coagulation and Fibrinolysis
- (2008) Franziska Geiser et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- The HPA axis in major depression: classical theories and new developments
- (2008) Carmine M. Pariante et al. TRENDS IN NEUROSCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started